Navigation Links
Gerry A. Higgins, Ph.D. Joins GenomeQuest to Foster Development of Whole Genome Diagnostics
Date:6/9/2011

WESTBOROUGH, Mass., June 9, 2011 /PRNewswire/ -- GenomeQuest Inc. today announced it has appointed Gerry A. Higgins, Ph.D., a nationally recognized scientist and pioneer in genomics research, as the company's first Healthcare Innovation Officer. In his new role, Dr. Higgins will focus on applying the company's proprietary technology to the development of whole genome and multi-gene diagnostics for the medical community, working closely with clinicians at hospitals and academic research centers, and partnering with commercial laboratories and pharmaceutical companies.

"A major challenge of pushing whole genome diagnostics beyond the research project stage and toward a routine test to be used by laboratories and hospitals is how to manage and interpret massive volumes of gene sequence data," Dr. Higgins said. "I joined GenomeQuest because they offer the technology to make whole genome diagnostics available to patients today – not 10 years from now."

Dr. Higgins brings a wealth of relevant knowledge and experience in the corporate, federal and academic sectors to help fortify GenomeQuest's position as the global leader in sequence data management. Most recently, Dr. Higgins was lead author of a report from the National Institutes of Health titled Information Technology Assessment Report and Strategic Roadmap on Biomedical Informatics and Computational Biology. The report addresses how NIH can help advance personalized medicine to the clinic. He also has served as vice president for Hoffmann-La Roche Pharmaceuticals, helping integrate personalized medicine into the company's product line. Previously, he was director of clinical informatics and chief innovation officer for MedStar Health, a large ten hospital network, where he focused on the integration of genomics into electronic health records. In 2001, Dr. Higgins founded and raised financing for a start-up company, SimQuest, a Silver Spring, Maryland company that focused on biomedical informatics, medical modeling and simulation. After selling the company to Laerdal Medical Corporation, he went on to serve as US vice president of R&D.

Dr. Higgins has obtained more than $65 million in grants, contracts and corporate funding for research and development projects, and he has authored more than 330 peer-reviewed publications, books and technical monographs. Additionally, he has authored more than 15 research roadmaps in biomedical informatics, biomarker databases, medical simulation and advanced learning technologies for both federal research and non-profit organizations.

"Gerry is a critical hire for us as we advance our company into the rapidly-advancing whole genome diagnostics market," said GenomeQuest Chief Executive Officer Richard Resnick. "His knowledge and experience at the intersection of clinical care and bioinformatics will be instrumental in making us the go-to company for delivering diagnostics at multi-gene and whole genome scales."

About GenomeQuest

GenomeQuest, the global leader in sequence data management, helps life science organizations realize the full promise of genomics. The core technology of the company is the GQ-Engine—a sequence database engine that is purpose-built for storing, managing and analyzing sequence data at whole- and multi-genome scale. GenomeQuest serves nine of the top 10 pharmaceutical companies and is a research standard at Syngenta, Biogemma and other leading agricultural companies.  Learn more at www.genomequest.com.


'/>"/>
SOURCE GenomeQuest Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Yuemeng Dai, M.D., Ph.D., ear, nose and throat specialist, receives Bill Potsic Basic Science Award
2. Michael S. Watson, Ph.D., receives Am College of Medical Genetics-ACMG Foundation Presidents Award
3. Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics
4. Ph.D. thesis describes 35 hitherto unknown families of endogenous retroviruses
5. Autism Speaks chief science officer Geraldine Dawson, Ph.D., named Rock Star of Science
6. Ph.D. thesis opens doors to obtaining chemical products and materials using biomass as raw material
7. The Reaxys Ph.D. Prize awards innovative research in organic, organometallic and inorganic chemistry
8. Geraldine Dawson, Ph.D. of Autism Speaks appointed to NIH Interagency Autism Coordinating Committee
9. Marwan Khaled Tayeh, Ph.D., is awarded the 2010 Richard King Trainee Award
10. UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students
11. Ph.D. student in K-State plant pathology selected for international fellowship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
Breaking Biology Technology: